(Post-pandemic Era)-Global The Gabapentin Enacarbil Market Segment Research Report 2023

Report ID: 875088 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Gabapentin Enacarbil Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Gabapentin Enacarbil Market by Value
      2.2.1 Global The Gabapentin Enacarbil Revenue by Type
      2.2.2 Global The Gabapentin Enacarbil Market by Value (%)
    2.3 Global The Gabapentin Enacarbil Market by Production
      2.3.1 Global The Gabapentin Enacarbil Production by Type
      2.3.2 Global The Gabapentin Enacarbil Market by Production (%)

3. The Major Driver of The Gabapentin Enacarbil Industry
    3.1 Historical & Forecast Global The Gabapentin Enacarbil Demand
    3.2 Largest Application for The Gabapentin Enacarbil (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Gabapentin Enacarbil Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Gabapentin Enacarbil Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Gabapentin Enacarbil Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Gabapentin Enacarbil Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Gabapentin Enacarbil Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Gabapentin Enacarbil Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Gabapentin Enacarbil Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Gabapentin Enacarbil Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Gabapentin Enacarbil Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Gabapentin Enacarbil Average Price Trend
    12.1 Market Price for Each Type of The Gabapentin Enacarbil in US (2017-2021)
    12.2 Market Price for Each Type of The Gabapentin Enacarbil in Europe (2017-2021)
    12.3 Market Price for Each Type of The Gabapentin Enacarbil in China (2017-2021)
    12.4 Market Price for Each Type of The Gabapentin Enacarbil in Japan (2017-2021)
    12.5 Market Price for Each Type of The Gabapentin Enacarbil in India (2017-2021)
    12.6 Market Price for Each Type of The Gabapentin Enacarbil in Korea (2017-2021)
    12.7 Market Price for Each Type of The Gabapentin Enacarbil in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Gabapentin Enacarbil Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Gabapentin Enacarbil

14. The Gabapentin Enacarbil Competitive Landscape
     14.1 Arbor Pharma
        14.1.1 Arbor Pharma Company Profiles
        14.1.2 Arbor Pharma Product Introduction
        14.1.3 Arbor Pharma The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Mylan
        14.2.1 Mylan Company Profiles
        14.2.2 Mylan Product Introduction
        14.2.3 Mylan The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Glenmark Pharma
        14.3.1 Glenmark Pharma Company Profiles
        14.3.2 Glenmark Pharma Product Introduction
        14.3.3 Glenmark Pharma The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Astellas
        14.4.1 Astellas Company Profiles
        14.4.2 Astellas Product Introduction
        14.4.3 Astellas The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Teva
        14.5.1 Teva Company Profiles
        14.5.2 Teva Product Introduction
        14.5.3 Teva The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 GlaxoSmithKline
        14.6.1 GlaxoSmithKline Company Profiles
        14.6.2 GlaxoSmithKline Product Introduction
        14.6.3 GlaxoSmithKline The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Apotex
        14.7.1 Apotex Company Profiles
        14.7.2 Apotex Product Introduction
        14.7.3 Apotex The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Depomed
        14.8.1 Depomed Company Profiles
        14.8.2 Depomed Product Introduction
        14.8.3 Depomed The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Pfizer
        14.9.1 Pfizer Company Profiles
        14.9.2 Pfizer Product Introduction
        14.9.3 Pfizer The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Novartis
        14.10.1 Novartis Company Profiles
        14.10.2 Novartis Product Introduction
        14.10.3 Novartis The Gabapentin Enacarbil Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Marksans Pharma
     14.12 Jiangsu Hengrui
     14.13 Sun Pharmaceutical
     14.14 Alkem
     14.15 Amneal
     14.16 Aurobindo Pharma
     14.17 Sailike Pharma
     14.18 Jiangsu Enhua
     14.19 Intas
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Gabapentin Enacarbil Industry (Volume)
    Figure 2. The Gabapentin Enacarbil Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Gabapentin Enacarbil Revenue in 2021
    Figure 5. US The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Gabapentin Enacarbil Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Gabapentin Enacarbil Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Gabapentin Enacarbil Production, by Type (K Unit) (2017-2027)
    Table 5. The Gabapentin Enacarbil Demand (K Unit) by Application (2017-2027)
    Table 6. The Gabapentin Enacarbil Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Gabapentin Enacarbil Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Gabapentin Enacarbil Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Gabapentin Enacarbil in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Arbor Pharma Profiles
    Table 61. Arbor Pharma The Gabapentin Enacarbil Product Introduction
    Table 62. Arbor Pharma The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Arbor Pharma Strategic initiatives
    Table 64. Mylan Profiles
    Table 65. Mylan The Gabapentin Enacarbil Product Introduction
    Table 66. Mylan The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Mylan Strategic initiatives
    Table 68. Glenmark Pharma Profiles
    Table 69. Glenmark Pharma The Gabapentin Enacarbil Product Introduction
    Table 70. Glenmark Pharma The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Glenmark Pharma Strategic initiatives
    Table 72. Astellas Profiles
    Table 73. Astellas The Gabapentin Enacarbil Product Introduction
    Table 74. Astellas The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Astellas Strategic initiatives
    Table 76. Teva Profiles
    Table 77. Teva The Gabapentin Enacarbil Product Introduction
    Table 78. Teva The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Teva Strategic initiatives
    Table 80. GlaxoSmithKline Profiles
    Table 81. GlaxoSmithKline The Gabapentin Enacarbil Product Introduction
    Table 82. GlaxoSmithKline The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. GlaxoSmithKline Strategic initiatives
    Table 84. Apotex Profiles
    Table 85. Apotex The Gabapentin Enacarbil Product Introduction
    Table 86. Apotex The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Apotex Strategic initiatives
    Table 88. Depomed Profiles
    Table 89. Depomed The Gabapentin Enacarbil Product Introduction
    Table 90. Depomed The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Depomed Strategic initiatives
    Table 92. Pfizer Profiles
    Table 93. Pfizer The Gabapentin Enacarbil Product Introduction
    Table 94. Pfizer The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Pfizer Strategic initiatives
    Table 97. Novartis Profiles
    Table 98. Novartis The Gabapentin Enacarbil Product Introduction
    Table 99. Novartis The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Novartis Strategic initiatives
    Table 101. Marksans Pharma Profiles
    Table 102. Marksans Pharma The Gabapentin Enacarbil Product Introduction
    Table 103. Marksans Pharma The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Marksans Pharma Strategic initiatives
    Table 105. Jiangsu Hengrui Profiles
    Table 106. Jiangsu Hengrui The Gabapentin Enacarbil Product Introduction
    Table 107. Jiangsu Hengrui The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Jiangsu Hengrui Strategic initiatives
    Table 109. Sun Pharmaceutical Profiles
    Table 110. Sun Pharmaceutical The Gabapentin Enacarbil Product Introduction
    Table 111. Sun Pharmaceutical The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. Sun Pharmaceutical Strategic initiatives
    Table 113. Alkem Profiles
    Table 114. Alkem The Gabapentin Enacarbil Product Introduction
    Table 115. Alkem The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 116. Alkem Strategic initiatives
    Table 117. Amneal Profiles
    Table 118. Amneal The Gabapentin Enacarbil Product Introduction
    Table 119. Amneal The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 120. Amneal Strategic initiatives
    Table 121. Aurobindo Pharma Profiles
    Table 122. Aurobindo Pharma The Gabapentin Enacarbil Product Introduction
    Table 123. Aurobindo Pharma The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 124. Aurobindo Pharma Strategic initiatives
    Table 125. Sailike Pharma Profiles
    Table 126. Sailike Pharma The Gabapentin Enacarbil Product Introduction
    Table 127. Sailike Pharma The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 128. Sailike Pharma Strategic initiatives
    Table 129. Jiangsu Enhua Profiles
    Table 130. Jiangsu Enhua The Gabapentin Enacarbil Product Introduction
    Table 131. Jiangsu Enhua The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 132. Jiangsu Enhua Strategic initiatives
    Table 133. Intas Profiles
    Table 134. Intas The Gabapentin Enacarbil Product Introduction
    Table 135. Intas The Gabapentin Enacarbil Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Gabapentin Enacarbil Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Gabapentin Enacarbil Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Gabapentin Enacarbil Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports